ENDRA Life Sciences Inc (NASDAQ: NDRA) is -99.80% lower on its value in year-to-date trading and has touched a low of $0.18 and a high of $139.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NDRA stock was last observed hovering at around $0.21 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.21, the stock is 0.17% and -75.01% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.9 million and changing -0.48% at the moment leaves the stock -99.08% off its SMA200. NDRA registered -99.59% loss for a year compared to 6-month loss of -98.40%. The firm has a 50-day simple moving average (SMA 50) of $0.8373 and a 200-day simple moving average (SMA200) of $22.716576.
The stock witnessed a -9.13% gain in the last 1 month and extending the period to 3 months gives it a -95.49%, and is 3.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.91% over the week and 8.89% over the month.
ENDRA Life Sciences Inc (NDRA) has around 21 employees, a market worth around $3.79M and $0.00M in sales. Distance from 52-week low is 15.21% and -99.85% from its 52-week high. The company has generated returns on investments over the last 12 months (-105.20%).
The EPS is expected to grow by 85.97% this year.
ENDRA Life Sciences Inc (NDRA) Top Institutional Holders
15.0 institutions hold shares in ENDRA Life Sciences Inc (NDRA), with institutional investors hold 0.09% of the company’s shares. The shares outstanding are 18.14M, and float is at 18.14M with Short Float at 1.48%. Institutions hold 0.09% of the Float.
ENDRA Life Sciences Inc (NDRA) Insider Activity
The most recent transaction is an insider purchase by UBS Group AG, the company’s 10% Owner. SEC filings show that UBS Group AG bought 3,715 shares of the company’s common stock on Aug 27 ’24 at a price of $0.55 per share for a total of $2052.0. Following the purchase, the insider now owns 0.15 million shares.
